126 related articles for article (PubMed ID: 8713579)
21. Analysis of the immunoglobulin heavy chain gene variable region of intravascular large B-cell lymphoma.
Kanda M; Suzumiya J; Ohshima K; Haraoka S; Nakamura N; Abe M; Tamura K; Kikuchi M
Virchows Arch; 2001 Oct; 439(4):540-6. PubMed ID: 11710641
[TBL] [Abstract][Full Text] [Related]
22. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma.
Nakamura N; Hashimoto Y; Kuze T; Tasaki K; Sasaki Y; Sato M; Abe M
Lab Invest; 1999 Aug; 79(8):925-33. PubMed ID: 10462030
[TBL] [Abstract][Full Text] [Related]
24. [CD8-positive diffuse large B-cell lymphoma].
Noguchi M; Sakamoto N; Okumura K; Sato N; Yamada K; Isobe Y; Kato A; Oshimi K
Rinsho Ketsueki; 2000 Jul; 41(7):591-5. PubMed ID: 11020983
[TBL] [Abstract][Full Text] [Related]
25. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
26. The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?
Chang QA; Qasem A; Madhusudhana S; Glazyrin A
Int J Clin Exp Pathol; 2015; 8(8):9602-8. PubMed ID: 26464726
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive and -negative diffuse large B cell lymphoma.
Nakamura N; Kuze T; Hashimoto Y; Hara Y; Hoshi S; Sasaki Y; Shirakawa A; Sato M; Abe M
Leukemia; 2001 Mar; 15(3):452-7. PubMed ID: 11237070
[TBL] [Abstract][Full Text] [Related]
28. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
29. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
[TBL] [Abstract][Full Text] [Related]
30. CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.
Vassallo J; Bousquet M; Quelen C; Al Saati T; Delsol G; Brousset P
J Clin Pathol; 2007 May; 60(5):573-5. PubMed ID: 17513519
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
32. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
[TBL] [Abstract][Full Text] [Related]
33. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
[TBL] [Abstract][Full Text] [Related]
34. MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.
Muñoz-Mármol AM; Sanz C; Tapia G; Marginet R; Ariza A; Mate JL
Histopathology; 2013 Sep; 63(3):418-24. PubMed ID: 23795946
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ
Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178
[TBL] [Abstract][Full Text] [Related]
36. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
37. De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema.
Dargent JL; Lespagnard L; Feoli F; Debusscher L; Greuse M; Bron D
Leuk Lymphoma; 2005 May; 46(5):775-80. PubMed ID: 16019518
[TBL] [Abstract][Full Text] [Related]
38. [CD5 positive B cell leukemic lymphoma associated with BCL6 rearrangement].
Hirai H; Shimura K; Takahashi R; Kikuta T; Ashihara E; Inada T; Fujita N; Shimazaki C; Akasaka T; Ohno H; Nakagawa M
Rinsho Ketsueki; 1999 Nov; 40(11):1198-200. PubMed ID: 10624132
[TBL] [Abstract][Full Text] [Related]
39. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
[TBL] [Abstract][Full Text] [Related]
40. Expression of BTK/p-BTK is different between CD5
Duan N; Zhao M; Wang Y; Qu Y; Liu H; Wang H; Xing L; Shao Z
Hematology; 2019 Dec; 24(1):588-595. PubMed ID: 31392938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
